TWA
IOVA icon

TCI Wealth Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

TCI Wealth Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-555
Closed -$3.39K – 1178
2023
Q1 		$3.39K Buy
+555
New +$3.83K ﹤0.01% 1781
2022
Q4 		– Sell
-466
Closed -$4K – 2581
2022
Q3 		$4K Hold
466
– – ﹤0.01% 1617
2022
Q2 		$5K Buy
466
+428
+1,126% +$5.61K ﹤0.01% 1492
2022
Q1 		$1K Buy
+38
New +$588 ﹤0.01% 2110
2021
Q3 		– Sell
-17
Closed – – 2474
2021
Q2 		$0 Hold
17
– – ﹤0.01% 2381
2021
Q1 		$1K Sell
17
-1
-6% -$41 ﹤0.01% 2080
2020
Q4 		$1K Hold
18
– – ﹤0.01% 1397
2020
Q3 		$1K Hold
18
– – ﹤0.01% 1345
2020
Q2 		$0 Buy
+18
New +$592 ﹤0.01% 1553

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return